MPM BioImpact Expands into SE Asia via Singapore
13 Aug 2026
US$ 20.00
US-based MPM BioImpact has provided US$50 m in seed financing to the Singapore-based K2 Therapeutics Pte Ltd (K2) which...
Related Publications
Subscribers’ Weekly for the week ending 14 Aug 2026...
Listen to Subscribers' Weekly 14 Aug 2026...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.